FOSTAMATINIB vs FREMANEZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
FOSTAMATINIB vs FREMANEZUMAB: Safety Overview
| Metric | FOSTAMATINIB | FREMANEZUMAB |
|---|---|---|
| Total FAERS Reports | 6,394 | 224 |
| Deaths Reported | 453 | 2 |
| Death Rate | 7.1% | 0.9% |
| Hospitalizations | 1,493 | 39 |
| Average Patient Age | 64.7 yrs | 47.1 yrs |
| % Female Patients | 60.8% | 88.8% |
| FDA Approval Date | Apr 17, 2018 | N/A |
| Manufacturer | Rigel Pharmaceuticals, Inc. | Teva Pharmaceuticals USA, Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | N/A |